John Koudounis, President and CEO of Calamos, a leading alternatives manager, announced the launch of the Calamos Aksia Private Equity & Alternatives Fund (Ticker: CAPVX). The Fund is designed to provide investors with access to a diversified portfolio of private equity investments across buyouts, growth equity, and venture capital. CAPVX will focus on investing in […]

Cognition Therapeutics Study of Zervimesine (CT1812) in Early Alzheimer's Disease Surpasses 50% Enrollment Target GlobeNewswire July 01, 2025 PURCHASE, N.Y., July 01, 2025 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, announced that the Phase 2 'START' Study surpasses 50% enrollment.

Costamare Inc. Declares Quarterly Dividend on Its Preferred and Common Stock GlobeNewswire July 01, 2025 MONACO, July 01, 2025 (GLOBE NEWSWIRE) — Costamare Inc. (the “Company”) (NYSE: CMRE) has declared cash dividends of US $0.476563 per share on its 7.625% Series B Cumulative Redeemable Perpetual Preferred Stock (the “Series B Preferred Stock”) (NYSE: CMRE PR

Adaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ(R) MRD Testing into OncoEMR(R) GlobeNewswire July 01, 2025 SEATTLE, July 01, 2025 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, and Flatiron

TWL Miner Announces Advancements in AI-Powered Cloud Mining Infrastructure Following $95 Million Series B Funding TWL Miner, a UK-based cloud mining platform established in 2019, has announced the successful completion of its Series B funding round, securing $95 million to support the integration of artificial intelligence technologies into its cloud mining operations. GlobeNewswire July 01,

Abeona Therapeutics(R) Announces Option Exercise by Beacon Therapeutics for Novel AAV204 Capsid for Ophthalmology Gene Therapy Abeona will receive a license payment and potential development, regulatory, and sales milestones, and royalties GlobeNewswire July 01, 2025 CLEVELAND, July 01, 2025 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that Beacon Therapeutics, an ophthalmic gene

FinWise Bancorp to Host Second Quarter 2025 Earnings Conference Call and Webcast on Thursday, July 24, 2025 GlobeNewswire July 01, 2025 MURRAY, Utah, July 01, 2025 (GLOBE NEWSWIRE) — FinWise Bancorp (NASDAQ: FINW) (“FinWise” or the “Company”), the parent company of FinWise Bank, today announced that it will report its second quarter 2025 results and

Nexxen Announces June 2025 Share Repurchase Program Summary GlobeNewswire July 01, 2025 NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced that during June 2025 the Company repurchased 800,000 Ordinary Shares

Sonoco To Report Second Quarter 2025 Results GlobeNewswire July 01, 2025 HARTSVILLE, S.C., July 01, 2025 (GLOBE NEWSWIRE) — Sonoco Products Company (“Sonoco” or the “Company”)(NYSE: SON), a global leader in high-value sustainable packaging, will announce second quarter 2025 results on Wednesday, July 23, 2025, after the market closes. The Company will host a conference

Watsco Declares $3.00 Quarterly Dividend Marks 200th Consecutive Quarter of Dividend Payments GlobeNewswire July 01, 2025 MIAMI, July 01, 2025 (GLOBE NEWSWIRE) — Watsco, Inc.'s (NYSE: WSO) Board of Directors has declared a regular quarterly cash dividend of $3.00 on each outstanding share of its Common and Class B common stock payable on July 31,